Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Questionnaires
2.3. Population
2.4. Recruitment
2.5. Statistical Considerations
3. Results
3.1. Test–Retest Reliability
3.2. Factor Analysis
3.3. Baseline Differences
3.4. Acceptability
4. Discussion
4.1. mPCOSQ
4.2. PCOSQOL
4.3. Strengths, Limitations, and Future Research
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- March, W.A.; Moore, V.M.; Willson, K.J.; Phillips, D.I.; Norman, R.J.; Davies, M.J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. J. Hum. Reprod. 2010, 25, 544–551. [Google Scholar] [CrossRef] [Green Version]
- Bozdag, G.; Mumusoglu, S.; Zengin, D.; Karabulut, E.; Yildiz, B.O. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. 2016, 31, 2841–2855. [Google Scholar] [CrossRef] [PubMed]
- Azziz, R.; Carmina, E.; Chen, Z.; Dunaif, A.; Laven, J.S.; Legro, R.S.; Lizneva, D.; Natterson-Horowtiz, B.; Teede, H.J.; Yildiz, B.O. Polycystic ovary syndrome. Nat. Rev. Dis. Primers 2016, 2, 16057. [Google Scholar] [CrossRef] [PubMed]
- ESHRE, R. ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004, 81, 19–25. [Google Scholar]
- Laven, J.S.; Imani, B.; Eijkemans, M.J.; Fauser, B.C. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet. Gynecol. Surv. 2002, 57, 755–767. [Google Scholar] [CrossRef]
- Veltman-Verhulst, S.M.; Boivin, J.; Eijkemans, M.J.; Fauser, B.J. Emotional distress is a common risk in women with polycystic ovary syndrome: A systematic review and meta-analysis of 28 studies. Hum. Reprod. Update 2012, 18, 638–651. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Teede; Deeks, A.; Moran, L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010, 8, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cooney, L.G.; Lee, I.; Sammel, M.D.; Dokras, A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. 2017, 32, 1075–1091. [Google Scholar] [CrossRef] [Green Version]
- Kitzinger, C.; Willmott, J. ‘The thief of womanhood’: Women’s experience of polycystic ovarian syndrome. Soc. Sci. Med. 2002, 54, 349–361. [Google Scholar] [CrossRef]
- McCook, J.G.; Reame, N.E.; Thatcher, S.S. Health-related quality of life issues in women with polycystic ovary syndrome. J. Obstet. Gynecol. Neonatal Nurses 2005, 34, 12–20. [Google Scholar] [CrossRef] [Green Version]
- Jones, G.L.; Hall, J.M.; Balen, A.H.; Ledger, W.L. Health-related quality of life measurement in women with polycystic ovary syndrome: A systematic review. Hum. Reprod. Update 2008, 14, 15–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Teede; Misso, M.L.; Costello, M.F.; Dokras, A.; Laven, J.; Moran, L.; Piltonen, T.; Norman, R.J.; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 2018, 110, 364–379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cronin, L.; Guyatt, G.; Griffith, L.; Wong, E.; Azziz, R.; Futterweit, W.; Cook, D.; Dunaif, A. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J. Clin. Endocrinol. Metab. 1998, 83, 1976–1987. [Google Scholar] [CrossRef] [PubMed]
- Aaronson, N.K.; Muller, M.; Cohen, P.D.; Essink-Bot, M.L.; Fekkes, M.; Sanderman, R.; Sprangers, M.A.; te Velde, A.; Verrips, E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J. Clin. Epidemiol. 1998, 51, 1055–1068. [Google Scholar] [CrossRef] [PubMed]
- Jones, G.L.; Benes, K.; Clark, T.L.; Denham, R.; Holder, M.G.; Haynes, T.J.; Mulgrew, N.C.; Shepherd, K.E.; Wilkinson, V.H.; Singh, M.; et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): A validation. Hum. Reprod. 2004, 19, 371–377. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guyatt, G.; Weaver, B.; Cronin, L.; Dooley, J.A.; Azziz, R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J. Clin. Epidemiol. 2004, 57, 1279–1287. [Google Scholar] [CrossRef]
- Alghadeer, S.; Algarawi, A.; Abu-Rkybah, F.; Alshebly, M.M.; Alruthia, Y. The translation and validation of the Arabic Version of the Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (AR-PCOSQ). BMC Womens Health 2020, 20, 244. [Google Scholar] [CrossRef]
- Bottcher, B.; Fessler, S.; Friedl, F.; Toth, B.; Walter, M.H.; Wildt, L.; Riedl, D. Health-related quality of life in patients with polycystic ovary syndrome: Validation of the German PCOSQ-G. Arch. Gynecol. Obs. 2018, 297, 1027–1035. [Google Scholar] [CrossRef] [Green Version]
- Ou, H.T.; Wu, M.H.; Lin, C.Y.; Chen, P.C. Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ). PLoS ONE 2015, 10, e0137772. [Google Scholar] [CrossRef]
- Jedel, E.; Kowalski, J.; Stener-Victorin, E. Assessment of health-related quality of life: Swedish version of polycystic ovary syndrome questionnaire. Acta Obs. Gynecol. Scand. 2008, 87, 1329–1335. [Google Scholar] [CrossRef]
- Bazarganipour, F.; Ziaei, S.; Montazeri, A.; Faghihzadeh, S.; Frozanfard, F. Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire. Hum. Reprod. 2012, 27, 2729–2736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Malik-Aslam, A.; Reaney, M.D.; Speight, J. The suitability of polycystic ovary syndrome-specific questionnaires for measuring the impact of PCOS on quality of life in clinical trials. Value Health 2010, 13, 440–446. [Google Scholar] [CrossRef] [PubMed]
- Barry, J.A.; Leite, N.; Sivarajah, N.; Keevil, B.; Owen, L.; Miranda, L.C.; Qu, F.; Hardiman, P. Relaxation and guided imagery significantly reduces androgen levels and distress in Polycystic Ovary Syndrome: Pilot study. Contemp. Hypn. Integr. Ther. 2017, 32, 21–29. [Google Scholar]
- Williams, S.; Sheffield, D.; Knibb, R.C. The Polycystic Ovary Syndrome Quality of Life scale (PCOSQOL): Development and preliminary validation. Health Psychol. Open 2018, 5, 2055102918788195. [Google Scholar] [CrossRef] [Green Version]
- Gibson-Helm, M.; Teede, H.; Dunaif, A.; Dokras, A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2017, 102, 604–612. [Google Scholar] [CrossRef] [Green Version]
- Barnard, L.; Ferriday, D.; Guenther, N.; Strauss, B.; Balen, A.H.; Dye, L. Quality of life and psychological well being in polycystic ovary syndrome. Hum. Reprod. 2007, 22, 2279–2286. [Google Scholar] [CrossRef] [Green Version]
- Balen, A.H.; Laven, J.S.E.; Tan, S.L.; Dewailly, D. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum. Reprod. Update 2003, 9, 505–514. [Google Scholar] [CrossRef]
- Bonett, D.G.; Wright, T.A. Sample size requirements for estimating Pearson, Kendall and Spearman correlations. Psychometrika 2000, 65, 23–28. [Google Scholar] [CrossRef]
Characteristics | Belgium (IQR) | The Netherlands (IQR) |
---|---|---|
N = 64 | N = 181 | |
Median age (years) | 31.0 (28.0–33.8) | 30.0 (27.0–34.0) |
Median weight (kg) | 69.0 (58–80.8) | 82.0 (70.0–100.0) |
Median body mass index (BMI) (kg/m2) | 30.0 (25.3–35.5) | 34.3 (28.7–40.5) |
N (%) | N (%) | |
Time since PCOS diagnosis: | ||
<1 year | 16 (25.0) | 27 (14.9) |
1 to 5 years | 31 (48.4) | 77 (42.4) |
5 to 10 years | 9 (14.1) | 43 (23.8) |
>10 years | 8 (12.5) | 34 (18.8) |
Trying to conceive (yes) | 27 (42.2) | 62 (34.3) |
Marital status (married) | 21 (32.8) | 79 (43.6) |
Education: | ||
Low | 12 (18.8) | 6 (3.3) |
Intermediate | 2 (3.1) | 84 (46.4) |
High | 50 (78.1) | 91 (50.3) |
Working status (full time) | 46 (71.9) | 65 (35.9) |
Smoking (yes) | 3 (4.7) | 18 (9.9) |
Alcohol use (yes) | 40 (62.5) | 103 (56.9) |
Drug use (yes) | 1 (1.6) | 4 (2.2) |
Questionnaire | Domain | Median Score T0 (Min–Max) | Median Score T1 (Min–Max) | Cronbach’s Alpha (α) | ICC (95% CI) |
---|---|---|---|---|---|
mPCOSQ | Emotions | 3.8 (1–7) | 4.1 (1–7) | 0.919 | 0.92 (0.90–0.94) |
Body hair | 3.8 (1–7) | 3.8 (1–7) | 0.959 | 0.96 (0.95–0.97) | |
Weight | 3.0 (1–7) | 2.8 (1–7) | 0.955 | 0.96 (0.94–0.97) | |
Infertility | 3.8 (1–7) | 4.0 (1–7) | 0.932 | 0.93 (0.90–0.95) | |
Menstrual problems | 3.3 (1–7) | 3.3 (1–7) | 0.879 | 0.88 (0.84–0.90) | |
Acne | 5.8 (1–7) | 5.8 (1–7) | 0.916 | 0.92 (0.89–0.94) | |
PCOSQOL | Impact of PCOS | 3.9 (1–7) | 3.9 (1–7) | 0.952 | 0.95 (0.94–0.96) |
Infertility | 4.6 (1–7) | 4.6 (1–7) | 0.951 | 0.95 (0.94–0.96) | |
Hirsutism | 4.5 (1–7) | 4.3 (1–7) | 0.961 | 0.96 (0.95–0.97) | |
Mood | 4.2 (1–7) | 4.2 (1–7) | 0.914 | 0.91 (0.89–0.93) |
Questionnaire | Domain | Overall Score (SD) | Score for Belgium (SD) | Score for The Netherlands (SD) | p Value |
---|---|---|---|---|---|
mPCOSQ | Emotions | 3.99 (1.36) | 4.93 (1.37) | 3.65 (1.19) | <0.001 |
Body hair | 4.00 (2.03) | 4.92 (2.01) | 3.67 (1.95) | <0.001 | |
Weight | 3.59 (2.19) | 4.61 (2.10) | 3.22 (2.11) | <0.001 | |
Infertility | 3.73 (1.94) | 4.37 (2.08) | 3.50 (1.84) | 0.002 | |
Menstrual problems | 3.41 (1.40) | 3.96 (1.67) | 3.22 (1.24) | 0.003 | |
Acne | 5.17 (1.75) | 5.43 (1.65) | 5.09 (1.78) | 0.167 | |
Total score (with acne) | 3.97 (1.20) | 4.74 (1.24) | 3.70 (1.07) | <0.001 | |
Total score (without acne) | 3.78 (1.28) | 4.63 (1.28) | 3.48 (1.14) | <0.001 | |
PCOSQOL | Impact of PCOS | 4.00 (1.47) | 4.88 (1.47) | 3.70 (1.35) | <0.001 |
Infertility | 4.38 (1.92) | 4.74 (1.89) | 4.26 (1.92) | 0.094 | |
Hirsutism | 4.29 (1.88) | 5.13 (1.74) | 3.99 (1.84) | <0.001 | |
Mood | 3.99 (1.42) | 4.91 (1.17) | 3.67 (1.36) | <0.001 | |
Total score | 4.13 (1.31) | 4.90 (1.23) | 3.86 (1.23) | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jiskoot, G.; Somers, S.; De Roo, C.; Stoop, D.; Laven, J. Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS. J. Clin. Med. 2023, 12, 3927. https://doi.org/10.3390/jcm12123927
Jiskoot G, Somers S, De Roo C, Stoop D, Laven J. Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS. Journal of Clinical Medicine. 2023; 12(12):3927. https://doi.org/10.3390/jcm12123927
Chicago/Turabian StyleJiskoot, Geranne, Sara Somers, Chloë De Roo, Dominic Stoop, and Joop Laven. 2023. "Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS" Journal of Clinical Medicine 12, no. 12: 3927. https://doi.org/10.3390/jcm12123927